AbbVie DSO Ratio 2011-2026 | ABBV

Annual DSO Ratio AbbVie

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
258	71.5	75.3	66.7	61	56.8	59.6	60	65.8	67.7	75.5	78.5	93.3	85.4	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
258	56.8	83.9

Quarterly DSO Ratio AbbVie

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
73.5	74.3	81.9	73.2	74.7	86.6	75	75.6	84.8	-	33.1	33.6	69.8	59	61.1	63.7	64.6	58.1	62.4	77.2	75.4	56.9	58.4	60	63	59.2	59.6	59.4	60.2	60	66.4	66.9	68.7	65.5	69.2	67.3	72.7	66.3	71.4	78.8	76.6	62.5	67.9	69.2	75.9	68.8	75.5	75	85.9	75.3	87	87.3	47	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
87.3	33.1	68.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.6	$ 0.88	-2.07 %	$ 6.47 M	China
ACADIA Pharmaceuticals ACAD	37.5	$ 22.67	1.66 %	$ 3.76 B	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	87.4	-	-	$ 35.4 M	USA
ChromaDex Corporation CDXC	24.7	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	103	$ 4.09	-0.24 %	$ 437 M	USA
Arcutis Biotherapeutics ARQT	106	$ 23.29	-0.56 %	$ 2.96 B	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	4.23 %	$ 394 M	Britain
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.91	0.34 %	$ 4.79 M	Israel
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Evogene Ltd. EVGN	30	$ 0.79	1.28 %	$ 27.9 M	Israel
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Cardiff Oncology CRDF	294	$ 1.68	-2.33 %	$ 112 M	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
BioXcel Therapeutics BTAI	103	$ 1.06	-2.75 %	$ 12.9 M	USA